MKC
DefensiveMcCormick & Company
Price Chart
Market Data
Financials
XBRL · SEC EDGAR2008–2025(18yr)| Metric | FY 2008 | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025Latest | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.2B | $3.2B | $3.3B | $3.7B | $4.0B | $4.1B | $4.2B | $4.3B | $4.4B | $4.8B | $5.4B | $5.3B | $5.6B | $6.3B | $6.4B | $6.7B | $6.7B | $6.8B | +1.7% |
| Gross Profit | $1.3B | $1.3B | $1.4B | $1.5B | $1.6B | $1.7B | $1.7B | $1.7B | $1.8B | $2.0B | $2.4B | $2.1B | $2.3B | $2.5B | $2.3B | $2.5B | $2.6B | $2.6B | +0.0% |
| Gross Margin | 40.6% | 41.6% | 42.5% | 41.2% | 40.3% | 40.4% | 40.8% | 40.4% | 41.5% | 41.6% | 43.8% | 40.1% | 41.1% | 39.5% | 35.8% | 37.6% | 38.5% | 37.9% | -0.6pp |
| Operating Income | $376.5M | $466.9M | $509.8M | $540.3M | $578.3M | $550.5M | $603.0M | $548.4M | $641.0M | $702.4M | $903.3M | $957.7M | $999.5M | $1.0B | $863.6M | $963.0M | $1.1B | $1.1B | +1.0% |
| Operating Margin | 11.9% | 14.6% | 15.3% | 14.6% | 14.4% | 13.4% | 14.2% | 12.8% | 14.5% | 14.5% | 16.7% | 17.9% | 17.8% | 16.1% | 13.6% | 14.5% | 15.8% | 15.7% | -0.1pp |
| Net Income | $255.8M | $299.8M | $370.2M | $374.2M | $407.8M | $389.0M | $437.9M | $401.6M | $472.3M | $477.4M | $933.4M | $702.7M | $747.4M | $755.3M | $682.0M | $680.6M | $788.5M | $789.4M | +0.1% |
| Net Margin | 8.1% | 9.4% | 11.1% | 10.1% | 10.2% | 9.4% | 10.3% | 9.3% | 10.7% | 9.9% | 17.3% | 13.1% | 13.3% | 12.0% | 10.7% | 10.2% | 11.7% | 11.5% | -0.2pp |
| Free Cash Flow | $228.8M | $333.4M | $298.5M | $243.3M | $344.7M | $365.3M | $370.9M | $461.6M | $504.3M | $632.9M | $652.1M | $773.1M | $816.0M | $550.3M | $389.5M | $973.4M | $647.0M | $740.4M | +14.4% |
| FCF Margin | 7.2% | 10.4% | 8.9% | 6.6% | 8.6% | 8.9% | 8.7% | 10.7% | 11.4% | 13.1% | 12.1% | 14.5% | 14.6% | 8.7% | 6.1% | 14.6% | 9.6% | 10.8% | +1.2pp |
| EPS (Diluted) | $1.94 | $2.27 | $2.75 | $2.79 | $3.04 | $2.91 | $3.34 | $3.11 | $3.69 | $3.72 | $7.00 | $5.24 | $2.78 | $2.80 | $2.52 | $2.52 | $2.92 | $2.93 | +0.3% |
1. THE BIG PICTURE
McCormick is attempting to evolve from a traditional spice supplier into a global flavor platform, but its premium valuation rests on a precarious balance of high margins and high debt. While its portfolio of "must-have" brands like Frank’s RedHot and Cholula allows for significant pricing power, McCormick & Company is increasingly reliant on acquisitions—such as its recent move in Mexico—to drive the top-line growth that its core organic business currently lacks.
2. WHERE THE RISKS HIT HARDEST
McCormick & Company’s "Customer Intimacy" and long-standing retail relationships are threatened by extreme Customer Concentration because just two buyers account for 24% of consolidated sales (10-K Item 1A). Any breakdown in these two relationships would not only collapse revenue but could trigger massive impairment charges against the $8.3 billion McCormick carries in goodwill and intangible assets. Furthermore, McCormick’s "Innovation" strategy is threatened by Raw Material Volatility; management admits that the price increases required to offset spikes in commodities like pepper and vanilla can trigger "price elasticity," which reduces the very sales volumes McCormick & Company is trying to grow (10-K Item 1).
3. WHAT THE NUMBERS SAY TOGETHER
McCormick operates with an enviable margin profile, maintaining a 37.8% gross margin and 11.8% net margin—both ranking second among its peer group (XBRL). However, this accounting profitability does not translate into superior cash generation. Its 5.8% free cash flow (FCFFCFFree Cash Flow — cash left after paying for operations and capital investments; what the company can actually spend, save, or return to shareholders) margin is among the lowest in the peer group, trailing Hershey’s 13.8% and Clorox’s 10.6% by a wide margin.
The 2026 guidance highlights a structural shift: while reported sales are projected to jump between 13% and 17%, organic sales growth is expected to remain a modest 1% to 3% (8-K). This divergence confirms that McCormick is currently buying its growth through deals like McCormick de Mexico rather than generating it through increased consumer demand. Market sentiment reflects some skepticism toward this trajectory, with short interest currently sitting at 11.7 million shares.
4. IS IT WORTH IT AT THIS PRICE?
At 18.8x Forward P/EP/EPrice-to-Earnings ratio — share price divided by annual earnings per share; how much investors pay per dollar of profit. Higher P/E = higher growth expectations, the market is pricing in approximately 2.3% long-term growth (CAPM analysis). This is "at fair value" relative to McCormick & Company’s actual organic growth trajectory of 1% to 3%, but it ignores the weight of the balance sheet. McCormick’s $4.3 billion in net debt represents roughly 11.0x its annual free cash flow, a significantly more aggressive leverage profile than peers like Hormel or Clorox.
While McCormick’s 15.7% operating margin is superior to the peer median, its low buyback yield (0.4%) and mid-pack dividend yield (3.0%) suggest that most excess cash is being diverted to debt service or acquisitions rather than shareholders. If organic growth remains at the low end of the 1% guidance, the current valuation premium over the peer median (17.0x) may be difficult to sustain.
5. WHAT WOULD CHANGE THIS VIEW?
- Cautious if organic volume growth in the Flavor Solutions segment remains negative, signaling that industrial food manufacturers are successfully reformulating products to avoid McCormick’s price increases.
- Constructive if the "Comprehensive Continuous Improvement" (CCI) program drives the FCFFCFFree Cash Flow — cash left after paying for operations and capital investments; what the company can actually spend, save, or return to shareholders margin toward the 10% peer average, allowing McCormick & Company to aggressively pay down its $4.0 billion debt load.
- Cautious if the implementation of the new global ERP system causes a "Supply Chain Disruption" at a major manufacturing site, as production for many products is concentrated in single locations (10-K Item 1A).
6. BOTTOM LINE
Structural Advantage: A dominant portfolio of high-margin, category-leading brands integrated into both retail shelves and the proprietary formulas of multinational food manufacturers.
Bottom Line: McCormick is a high-quality defensive business, but its current price leaves little upside for investors unless it can translate its high gross margins into much stronger free cash flow.
1. Top 5 Material Risks
- Customer Concentration: Two large customers represent approximately 24% of consolidated sales; the loss of either or a material change in these relationships could adversely affect financial results.
- Substantial Indebtedness: McCormick & Company holds approximately $4.0 billion in debt, which increases debt service obligations, limits borrowing capacity, and reduces flexibility to respond to adverse economic conditions.
- Asset Impairment: McCormick & Company carries $5.3 billion in goodwill and $3.0 billion in indefinite-lived intangible assets; changes in revenue growth rates, operating margins, or the weighted average cost of capital could trigger impairment charges.
- Raw Material Price Volatility: McCormick & Company is exposed to price fluctuations in key commodities—including dairy, pepper, garlic, onion, capsicums, salt, tomato products, sugar, and soybean oil—which may not be fully offset by price increases or hedging.
- Supply Chain Disruption: Production of certain products is highly concentrated, with some manufactured at a single location; disruptions due to natural disasters, geopolitical tensions, or third-party failures could impair the ability to manufacture or sell products.
2. Company-Specific Risks
- Business Transformation Execution: McCormick & Company is currently implementing a multi-year business transformation initiative, including a transition to a new enterprise resource planning (ERP) system; failure to achieve expected benefits or manage the transition could lead to transaction errors and loss of revenue.
- Pension Obligations: McCormick & Company maintains qualified defined benefit pension plans and a rabbi trust for a U.S. non-qualified plan; a decline in plan asset values or an increase in liabilities due to low interest rates could necessitate increased contributions, reducing cash available for working capital.
- Acquisition Integration: Recent activities, such as the acquisition of an additional 25% interest in McCormick de Mexico in January 2026, present risks related to the integration of personnel and systems, as well as the potential for unknown liabilities.
- CCI Program Reliance: McCormick & Company’s profitability depends on its Comprehensive Continuous Improvement (CCI) program to reduce costs; failure to realize these planned efficiencies could negatively affect financial results.
3. Regulatory/Legal Risks
- Food Safety and Labeling: McCormick & Company is subject to extensive regulation regarding food manufacturing and labeling, including California’s Proposition 65, which could require warning labels that negatively impact product sales.
- FDA and Health Commission Proposals: The FDA’s call to phase out petroleum-based synthetic dyes and the Make America Healthy Again (MAHA) Commission’s 2025 reports on chronic childhood disease introduce uncertainty regarding future regulatory requirements for ingredients.
- Data Privacy Compliance: McCormick & Company must comply with evolving global data privacy laws, such as the GDPR and the CCPA; failure to meet these standards or defend against related consumer class actions could result in significant financial penalties and reputational damage.
- Environmental and Sustainability Reporting: McCormick & Company has established science-based targets for greenhouse gas emissions; failure to achieve these goals or accurately report progress could lead to litigation, enforcement actions, or loss of investor confidence.
4. Financial Impact Map
Customer Concentration → Consolidated Sales → 24% of total sales derived from two customers in 2025. Substantial Indebtedness → Interest Expense / Cash Flow → $4.0 billion in total debt as of November 30, 2025, with $351.8 million in variable rate debt. Asset Impairment → Net Earnings / Profitability → $5.3 billion in goodwill and $3.0 billion in indefinite-lived intangible assets subject to annual or periodic testing. Raw Material Price Volatility → Cost of Goods Sold / Gross Margin → Exposure to price fluctuations in specific commodities like dairy, pepper, and soybean oil. Supply Chain Disruption → Operating Income → Potential for lost sales and increased costs to restore supply chain capabilities if production at concentrated or single-site facilities is interrupted.
Recent Filings
| Form | Filed | Period |
|---|---|---|
| 14A | Feb 2026 | — |
| 8-K | Jan 2026 | — |
| 10-K | Jan 2026 | Nov 2025 |
| 10-Q | Oct 2025 | Aug 2025 |
AI-extracted key facts from press releases and SEC filings. Significance 1–10.
McCormick to acquire Unilever food business via Reverse Morris Trust transaction
- ▸Reverse Morris Trust deal includes Hellmann’s, Colman’s, and Knorr brands
- ▸Unilever shareholders to own approximately two-thirds of combined entity
- ▸Transaction expected to be earnings-accretive in first year
- ▸McCormick to retain company name and NYSE listing
- ▸Stock fell 6% following deal announcement
McCormick to Acquire Unilever Foods for $44.8B Enterprise Value, Shares Fall 6.1%
- ▸Unilever Foods valued at $44.8B, or 13.8x 2025 adjusted EBITDA
- ▸McCormick paying $15.7B in cash as part of transaction
- ▸Combined company targets 3%-5% annual growth by year three
- ▸Projected $600M in annual cost synergies
- ▸Targeting 23%-25% operating margin by year three
Unilever shares drop 5% on food unit merger deal with McCormick & Company
- ▸Unilever shares fell 5% following merger announcement
- ▸McCormick & Company shares declined 6.1% on deal news
- ▸Merger involves Unilever's food unit and McCormick & Company
- ▸CoreWeave secured $8.5 billion loan for AI infrastructure expansion
- ▸AMD shares rose 3.8% amid broader semiconductor sector rally
McCormick to Merge With Unilever Foods in $44.8B Enterprise Value Deal
- ▸Combined entity to generate $20B in 2025 revenue
- ▸Unilever shareholders to receive $15.7B cash and 65% equity stake
- ▸Transaction values Unilever Foods at $44.8B and McCormick at $21.0B
- ▸Targeting $600M in annual cost synergies within three years
- ▸Combined portfolio includes Knorr, Hellmann’s, French’s, and Frank’s RedHot
MKC Q1 revenue $1.87B beats by 5.1%, adjusted EPS $0.66 beats by 10.9%
- ▸Revenue $1.87B, +16.7% YoY, beating estimates of $1.78B
- ▸Adjusted EPS $0.66, beating consensus estimates of $0.59
- ▸Adjusted EBITDA $336.3M, 6.4% above analyst estimates
- ▸FY26 adjusted EPS guidance reiterated at $3.09 midpoint
- ▸Sales volumes flat YoY despite acquisition-driven growth
McCormick to acquire Unilever food business for $44.8 billion in cash-and-stock deal
- ▸Acquisition values Unilever food business at $44.8 billion
- ▸Unilever shareholders to receive 65% stake in combined company plus $15.7 billion cash
- ▸Combined entity to generate over $20 billion in annual sales
- ▸Targeting $600 million in cost synergies within three years of closing
- ▸Combined company to carry 4.0x leverage ratio, targeting reduction to 3.0x within two years
McCormick to merge with Unilever food division in $44.8B transaction
- ▸Unilever shareholders to own 65% of combined entity, valued at $29.1B
- ▸Unilever to receive $15.7B in cash as part of transaction
- ▸Combined 2025 fiscal year revenue projected at $20B
- ▸Targeting $600M in annual cost synergies post-merger
- ▸Transaction expected to close by mid-2027 pending regulatory approval
McCormick to form $65B spice venture with Unilever via strategic partnership
- ▸Partnership with Unilever to create $65B spice entity
- ▸Strategy driven by century-long history of aggressive acquisitions
- ▸Consolidates global spice market share through joint venture
- ▸Combines McCormick expertise with Unilever global distribution scale
McCormick Q1 Revenue $1.87B Beats Estimates by 4.9%, EPS $0.66 Beats by 9.1%
- ▸Revenue $1.87B, +16.7% YoY, beating estimates of $1.79B
- ▸EPS $0.66, beating consensus estimate of $0.61
- ▸Consumer segment net sales $1.15B, +24.6% YoY
- ▸Flavor Solutions net sales $729M, +6.3% YoY
- ▸Consumer segment operating income $180M, beating $171.55M estimate
McCormick to Merge Food Business with Unilever in $20B Revenue Combination
- ▸Combined entity projected to generate $20B in FY25 revenue
- ▸Merger combines McCormick spice portfolio with Unilever food business
- ▸Transaction creates global food industry powerhouse
- ▸Market reaction negative following deal announcement